Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Shareholders??? Equity

v3.22.2.2
Condensed Consolidated Statements of Shareholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Deficit
Beginning balance (in shares) at Dec. 31, 2020   24,883,024    
Beginning balance at Dec. 31, 2020 $ 95,250 $ 0 $ 164,264 $ (69,014)
Increase (Decrease) in Shareholders' Equity [Roll Forward]        
Net Income (loss) (13,765)     (13,765)
Founders earn-out shares vested (in shares)   570,212    
Issuance of common shares upon vesting RSUs (in shares)   7,713    
Exercise of warrants (in shares)   122,639    
Exercise of warrants 1,410   1,410  
Stock-based compensation expense 1,550   1,550  
Ending balance (in shares) at Mar. 31, 2021   25,583,588    
Ending balance at Mar. 31, 2021 84,445 $ 0 167,224 (82,779)
Beginning balance (in shares) at Dec. 31, 2020   24,883,024    
Beginning balance at Dec. 31, 2020 95,250 $ 0 164,264 (69,014)
Increase (Decrease) in Shareholders' Equity [Roll Forward]        
Net Income (loss) (21,726)      
Ending balance (in shares) at Sep. 30, 2021   26,168,044    
Ending balance at Sep. 30, 2021 87,671 $ 0 178,411 (90,740)
Beginning balance (in shares) at Dec. 31, 2020   24,883,024    
Beginning balance at Dec. 31, 2020 $ 95,250 $ 0 164,264 (69,014)
Ending balance (in shares) at Dec. 31, 2021 26,605,797 26,605,797    
Ending balance at Dec. 31, 2021 $ 72,770 $ 0 187,510 (114,740)
Beginning balance (in shares) at Mar. 31, 2021   25,583,588    
Beginning balance at Mar. 31, 2021 84,445 $ 0 167,224 (82,779)
Increase (Decrease) in Shareholders' Equity [Roll Forward]        
Net Income (loss) (8,956)     (8,956)
Issuance of common shares upon vesting RSUs (in shares)   5,111    
Stock option exercise (in shares)   40,942    
Stock option exercise 10   10  
Stock-based compensation expense 3,323   3,323  
Ending balance (in shares) at Jun. 30, 2021   25,629,641    
Ending balance at Jun. 30, 2021 78,822 $ 0 170,557 (91,735)
Increase (Decrease) in Shareholders' Equity [Roll Forward]        
Net Income (loss) 995     995
Stock-based compensation expense 3,264   3,264  
Conversions of debt to common stock, net of debt issuance (in shares)   538,403    
Conversions of debt to common stock, net of debt issuance 4,590   4,590  
Ending balance (in shares) at Sep. 30, 2021   26,168,044    
Ending balance at Sep. 30, 2021 $ 87,671 $ 0 178,411 (90,740)
Beginning balance (in shares) at Dec. 31, 2021 26,605,797 26,605,797    
Beginning balance at Dec. 31, 2021 $ 72,770 $ 0 187,510 (114,740)
Increase (Decrease) in Shareholders' Equity [Roll Forward]        
Net Income (loss) (16,140)     (16,140)
Issuance of common shares upon vesting RSUs (in shares)   247,453    
Stock option exercise (in shares)   116,112    
Stock option exercise 22   22  
Stock-based compensation expense 500   500  
Issuance of common stock - gross (in shares)   11,047,567    
Issuance of common stock - gross 23,400   23,400  
Equity issuance costs (1,177)   (1,177)  
Conversions of Convertible Note to common shares (in shares)   607,000    
Conversions of Convertible Note to common shares 1,324   1,324  
Beneficial conversion feature 1,749   1,749  
Ending balance (in shares) at Mar. 31, 2022   38,623,929    
Ending balance at Mar. 31, 2022 $ 82,448 $ 0 213,328 (130,880)
Beginning balance (in shares) at Dec. 31, 2021 26,605,797 26,605,797    
Beginning balance at Dec. 31, 2021 $ 72,770 $ 0 187,510 (114,740)
Increase (Decrease) in Shareholders' Equity [Roll Forward]        
Net Income (loss) $ (37,349)      
Stock option exercise (in shares) 158,882      
Ending balance (in shares) at Sep. 30, 2022 43,571,444 43,571,444    
Ending balance at Sep. 30, 2022 $ 69,502 $ 0 221,591 (152,089)
Beginning balance (in shares) at Mar. 31, 2022   38,623,929    
Beginning balance at Mar. 31, 2022 82,448 $ 0 213,328 (130,880)
Increase (Decrease) in Shareholders' Equity [Roll Forward]        
Net Income (loss) (1,046)     (1,046)
Issuance of common shares upon vesting RSUs (in shares)   39,898    
Stock option exercise (in shares)   35,582    
Stock-based compensation expense 1,148   1,148  
Conversions of debt to common stock, net of debt issuance (in shares)   900,000    
Conversions of debt to common stock, net of debt issuance 2,039   2,039  
Ending balance (in shares) at Jun. 30, 2022   39,599,409    
Ending balance at Jun. 30, 2022 84,589 $ 0 216,515 (131,926)
Increase (Decrease) in Shareholders' Equity [Roll Forward]        
Net Income (loss) (20,163)     (20,163)
Issuance of common shares upon vesting RSUs (in shares)   24,837    
Stock-based compensation expense 958   958  
Issuance of common stock - gross (in shares)   3,947,198    
Issuance of common stock - gross 4,286   4,286  
Equity issuance costs $ (168)   (168)  
Ending balance (in shares) at Sep. 30, 2022 43,571,444 43,571,444    
Ending balance at Sep. 30, 2022 $ 69,502 $ 0 $ 221,591 $ (152,089)